| scholarly article | Q13442814 |
| P50 | author | Carlos S. Subauste | Q45702144 |
| P2093 | author name string | Jennifer A Greene | |
| Jose-Andres C Portillo | |||
| Isaac Schwartz | |||
| Maria Cecilia Subauste | |||
| P2860 | cites work | CD40 AND CD154 IN CELL-MEDIATED IMMUNITY | Q22255634 |
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| CD40-CD40 ligand | Q28143324 | ||
| Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. | Q30305868 | ||
| The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen | Q31129671 | ||
| Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile | Q33656103 | ||
| The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells | Q33711057 | ||
| The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease | Q33745206 | ||
| CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. | Q34324146 | ||
| Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. | Q34391220 | ||
| CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates | Q34433847 | ||
| Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes. | Q34724100 | ||
| CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes | Q35009488 | ||
| Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice | Q35160907 | ||
| Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype | Q35161070 | ||
| Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions | Q35621648 | ||
| CD40 ligation induces tissue factor expression in human vascular smooth muscle cells | Q35793488 | ||
| Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
| CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines | Q36065955 | ||
| Specific peptides for the therapeutic targeting of oncogenes | Q36353158 | ||
| Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis | Q36361382 | ||
| Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion | Q36366300 | ||
| CD40 and autoimmunity: the dark side of a great activator. | Q37365433 | ||
| Therapeutic applications of cell-penetrating peptides | Q37807348 | ||
| Matrix metalloproteinase inhibition therapy for vascular diseases | Q37983293 | ||
| TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells | Q39613693 | ||
| CD40 mediates retinal inflammation and neurovascular degeneration | Q39909768 | ||
| TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. | Q40474225 | ||
| CD40 signaling through a newly identified tumor necrosis factor receptor-associated factor 2 (TRAF2) binding site | Q40636873 | ||
| Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction. | Q40716536 | ||
| CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells | Q40804865 | ||
| Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions | Q40908092 | ||
| Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells | Q40911442 | ||
| Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T ce | Q41749032 | ||
| CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization | Q42060069 | ||
| TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells. | Q42509065 | ||
| Distinct contributions of different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and IL-12 secretion | Q44343215 | ||
| Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes | Q44599812 | ||
| CD40 ligand-dependent tyrosine nitration of prostacyclin synthase in vivo | Q46722560 | ||
| The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling | Q47245105 | ||
| CD40-mediated activation of vascular smooth muscle cell chemokine production through a Src-initiated, MAPK-dependent pathway | Q47306585 | ||
| IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro | Q47917213 | ||
| Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. | Q52041256 | ||
| Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. | Q52054451 | ||
| Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. | Q52526594 | ||
| Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? | Q52527039 | ||
| CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages. | Q53208850 | ||
| Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease | Q56906591 | ||
| Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides | Q67220163 | ||
| Mesangial expression of intercellular adhesion molecule-1 in primary glomerulosclerosis | Q67541892 | ||
| A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis | Q73114791 | ||
| Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 | Q73245727 | ||
| Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells | Q73302828 | ||
| Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions | Q73344118 | ||
| Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients | Q73351358 | ||
| Cell adhesion molecule expression in murine lupus-like nephritis induced by lipopolysaccharide | Q73407296 | ||
| Function of CD40/CD40L in peritubular capillary of renal allograft rejection | Q73667820 | ||
| Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice | Q73707721 | ||
| Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions | Q73812280 | ||
| Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys | Q74301083 | ||
| Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154 | Q74602347 | ||
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
| CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection | Q77317364 | ||
| Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats | Q77483148 | ||
| CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells | Q78068575 | ||
| The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching | Q78298237 | ||
| Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis | Q79187010 | ||
| CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages | Q79562635 | ||
| CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon | Q79835736 | ||
| The TRAF6, but not the TRAF2/3, binding domain of CD40 is required for cytokine production in human lung fibroblasts | Q81165279 | ||
| TNF receptor-associated factor 6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-alpha | Q81375615 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 21-33 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells | |
| P478 | volume | 144 |
| Q92169746 | CD40 in Endothelial Cells Restricts Neural Tissue Invasion by Toxoplasma gondii |
| Q40594560 | CD40 in Retinal Müller Cells Induces P2X7-Dependent Cytokine Expression in Macrophages/Microglia in Diabetic Mice and Development of Early Experimental Diabetic Retinopathy |
| Q35879683 | CD40-TRAF Signaling Upregulates CX3CL1 and TNF-α in Human Aortic Endothelial Cells but Not in Retinal Endothelial Cells |
| Q35924786 | Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway |
| Q32185814 | Ligation of CD40 in Human Müller Cells Induces P2X7 Receptor-Dependent Death of Retinal Endothelial Cells. |
| Q92618002 | MicroRNA-124 represents a novel diagnostic marker in human lupus nephritis and plays an inhibitory effect on the growth and inflammation of renal mesangial cells by targeting TRAF6 |
| Q38734421 | MicroRNA-126 Regulates Inflammatory Cytokine Secretion in Human Gingival Fibroblasts Under High Glucose Via Targeting Tumor Necrosis Factor Receptor Associated Factor 6. |
| Q92959413 | Role of NF-κB in Platelet Function |
| Q39141920 | Systematic analysis of chromatin interactions at disease associated loci links novel candidate genes to inflammatory bowel disease |
| Q92538952 | The CD40-ATP-P2X 7 Receptor Pathway: Cell to Cell Cross-Talk to Promote Inflammation and Programmed Cell Death of Endothelial Cells |
| Q35810718 | The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus |
Search more.